Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colorectal Neoplasms × Artesunate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Intestinal Neoplasms 2 Papillomavirus Infections 1 Malaria 1 Lymphoma, Follicular 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 CIN 2/3 1 Breast Neoplasms 1

Interventions

Fluorouracil 423 Bevacizumab 397 Oxaliplatin 376 Leucovorin 371 Irinotecan 346 Capecitabine 272 Cetuximab 270 pembrolizumab 122 Folfox protocol 112 Panitumumab 96 regorafenib 92 Colonoscopy 73 IFL protocol 72 Drug Therapy 67 Nivolumab 65 trifluridine tipiracil drug combination 60 Radiotherapy 59 HMPL-013 52 Blood Specimen Collection 49 Gemcitabine 43 Neoadjuvant Therapy 42 Specimen Handling 40 Chemotherapy, Adjuvant 38 Cyclophosphamide 37 Biopsy 37 Standard of Care 36 Surveys and Questionnaires 34 Magnetic Resonance Spectroscopy 34 atezolizumab 33 Trifluridine 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02633098 2022-10-12

NeoART

St George's, University of London

Phase 2 Unknown

Gastrointestinal

Intestinal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡